PARTICIPATING CLINICS

The Phase III clinical trial DIAGNODE-3 is open for recently diagnosed type 1 diabetes patients at selected clinics.

TAKING PART IN THE TRIAL

Contact a participating clinic to discuss with a doctor if participating in the clinical trial may be right for you. Participation is voluntary and you may discontinue participation at any time. Personal data is processed in accordance with applicable law. Further information about the trial may be obtained by contacting a clinic.

DIAGNODE-3
COORDINATING INVESTIGATOR
Professor Johnny Ludvigsson
  Crown Princess Victoria Children’s Hospital, Sweden
 

The importance of preserving your own remaining insulin production cannot be overstated. With more own insulin production the patient can more easily manage their diabetes and the risk of long-term complications is reduced. In this trial we investigate if we can preserve some of that insulin production for those with newly diagnosed type 1 diabetes. - Professor Johnny Ludvigsson


PARTICIPATING CLINICS

California

Newport Beach
Mary & Dick Allen Diabetes Center at Hoag Hospital
  520 Superior St. Newport Beach, CA 92663
Principal Investigator: Dr. David Ahn
 
Contact: Brittany Dennis
 
  949-764-6896
  RECRUITING

California

San Diego
UCSD/ Rady Children's Hospital
  3020 Children's Way, MC 5105 San Diego, CA 92123
Principal Investigator: Dr. Ron Newfield
 
Contact: Marla Hashiguchi
 
  858-966-8940
  NOT YET RECRUITING

California

Stanford
Stanford University School of Medicine Center for Academic Medicine
  453 Quarry Road, Stanford, CA 94304
Principal Investigator: Dr. Darrel Wilson
 
Contact: Trudy Esrey
 
  650-498-4450
  NOT YET RECRUITING

Colorado

Aurora
University of Colorado Anschutz Medical Campus, Barbara Davis Center for Childhood Diabetes
  1775 Aurora Court Aurora, CO 80045
Principal Investigator: Dr. Taylor Triolo
 
Contact: Fatima Tensun
 
  303-724-0064
  NOT YET RECRUITING

Florida

Miami
Diabetes Research Institute (DRI)-University of Miami Leonard M. Miller School of Medicine (UMMSM)
  1450 Northwest 10th Avenue Miami, FL 33136
Principal Investigator: Dr. David Baidal
 
Contact: Dr. Carlos Baschke
 
  305-243-4485
  RECRUITING

Idaho

Idaho Falls
Rocky Mountain Diabetes and Osteoporosis Center
  3910 Washington Parkway Idaho Falls, ID 83404
Principal Investigator: Dr Joshua Smith
 
Contact: Joann Malone
 
Contact: Joseph Rogers
 
  208-528-9650
  RECRUITING

Iowa

Iowa City
University of Iowa Hospital and Clinics
  200 Hawkins Dr. BT2015 Iowa City, IA52242
Principal Investigator: Dr. Michael Tansey
 
Contact: Brooke Burnett
 
  319-335-0077
  NOT YET RECRUITING

Maryland

Baltimore
Johns Hopkins
  600 N. Caroline St. #2008, Baltimore, MD 21287
Principal Investigator: Dr. Thomas Donner
 
Contact: Alexis Thomas
 
  443-814-9385
  RECRUITING

Massachusetts

Boston
Joslin Diabetes Center
  One Joslin Place Boston, MA 02215
Principal Investigator: Dr. Jason Gaglia
 
Contact: David Kim
 
  888-813-8669
  NOT YET RECRUITING

Missouri

St. Louis
Washington University Diabetes Center at Barnes Jewish Hospital
  4921 Parkview Pl, 13th floor, St. Louis, MO 63110
Principal Investigator: Dr. Janet McGill
 
Contact: Cameron Smith
 
  314-747-5371
  RECRUITING

New York

New York
Hassenfeld Children's Hospital at NYU Langone Health, Pediatric DiabetesCenter
  135 East 31st Street, Floor 2, NY 10016
Principal Investigator: Dr. Mary Gallagher
 
Contact: Jeniece Ilkowitz
 
  212-263-9910
  NOT YET RECRUITING

Texas

San Antonio
Diabetes & Glandular Disease Clinic
  5107 Medical Drive, San Antonio, TX 78237
Principal Investigator: Dr Mark Kipnes
 
Contact: Terri Ryan
 
  210-614-8612 ext 1630
  RECRUITING
 

SAFETY

Diamyd® has been administered to more than 1500 patients in clinical trials and has presented a favorable safety profile